Global Hepatic Fibrosis Biomarkers Market Size & Outlook
Global hepatic fibrosis biomarkers market, 2021-2033 (US$M)
Related Markets
Global hepatic fibrosis biomarkers market highlights
- The global hepatic fibrosis biomarkers market generated a revenue of USD 423.5 million in 2024 and is expected to reach USD 2,291.7 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 20.6% by 2033.
- In terms of segment, kits and assays accounted for a revenue of USD 203.5 million in 2024.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, Japan is expected to register the highest CAGR from 2025 to 2033.
Global data book summary
| Market revenue in 2024 | USD 423.5 million |
| Market revenue in 2033 | USD 2,291.7 million |
| Growth rate | 20.6% (CAGR from 2025 to 2033) |
| Largest segment | Kits and assays |
| Fastest growing segment | Services |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits and assays, Reagents, Services |
Other key industry trends
- In terms of revenue, the North America accounted for 48.9% of the global hepatic fibrosis biomarkers market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, Japan is the fastest growing regional market and is projected to reach USD 99.0 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hepatic Fibrosis Biomarkers Market Scope
Hepatic Fibrosis Biomarkers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| BioPredictive | View profile | 1-10 | Paris, Ile-de-France, France, Europe | https://www.biopredictive.com |
| Exalenz Bioscience | View profile | 11-50 | Union, New Jersey, United States, North America | http://www.exalenz.com/ |
| Siemens Healthineers AG | View profile | - | - | - |
| Bristol-Myers Squibb Company | View profile | - | - | - |
| The Prometheus Group | View profile | 1-10 | Dover, New Hampshire, United States, North America | https://theprogrp.com |
| AstraZeneca | View profile | 10001+ | Cambridge, Cambridgeshire, United Kingdom, Europe | http://www.astrazeneca.com |
| Pfizer | View profile | 10001+ | New York, New York, United States, North America | http://www.pfizer.com |
| Genfit SA | View profile | 159 | Parc Eurasante, 885, Avenue Eugene Avinee, Loos, France, 59120 | https://www.genfit.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
Global hepatic fibrosis biomarkers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hepatic fibrosis biomarkers market will help companies and investors design strategic landscapes.
Kits and assays was the largest segment with a revenue share of 48.05% in 2024. Horizon Databook has segmented the Global hepatic fibrosis biomarkers market based on kits and assays, reagents, services covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Hepatic Fibrosis Biomarkers Product Outlook (Revenue, USD Million, 2021-2033)
- Kits and assays
- Reagents
- Services
- Global Hepatic Fibrosis Biomarkers Technology Outlook (Revenue, USD Million, 2021-2033)
- Immunoassay
- Molecular Diagnostics
- Proteomics/Metabolomics
- Imaging-based Biomarker Assessment
- Global Hepatic Fibrosis Biomarkers End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Diagnostic Laboratories
- Specialty Clinics
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Reasons to subscribe to Global hepatic fibrosis biomarkers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global hepatic fibrosis biomarkers market databook
-
Our clientele includes a mix of hepatic fibrosis biomarkers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global hepatic fibrosis biomarkers market , including forecasts for subscribers. This global databook contains high-level insights into Global hepatic fibrosis biomarkers market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global hepatic fibrosis biomarkers market size, by regions, 2021-2033 (US$M)
Top 10 countries: Hepatic fibrosis biomarkers market size, 2024 (US$M)
Global hepatic fibrosis biomarkers market share, by product, 2024 & 2033 (%, US$M)
Hepatic fibrosis biomarkers market: Opportunity assessment by country
Global hepatic fibrosis biomarkers market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
